Natixis Outset Medical, Inc. Transaction History

Natixis

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$3.07 - $10.25 $33,303 - $111,192	-10,848 Reduced 19.19%	45,667 $247,000
Q3 2023 Nov 14, 2023	SELL	$10.52 - $20.68 $94,417 - $185,603	-8,975 Reduced 13.7%	56,515 $614,000
Q2 2023 Aug 11, 2023	SELL	$17.18 - $23.76 $6,356 - $8,791	-370 Reduced 0.56%	65,490 $1.43 Million
Q1 2023 May 12, 2023	SELL	$18.25 - $30.26 $1.27 Million - $2.11 Million	-69,790 Reduced 51.45%	65,860 $1.21 Million
Q4 2022 Feb 24, 2023	BUY	$12.36 - $26.41 $838,317 - $1.79 Million	67,825 Added 100.0%	135,650 $3.5 Million
Q4 2022 Feb 13, 2023	BUY	$12.36 - $26.41 $307,405 - $656,843	24,871 Added 57.9%	67,825 $1.75 Million
Q3 2022 Nov 14, 2022	SELL	$14.67 - $21.7 $28,049 - $41,490	-1,912 Reduced 4.26%	42,954 $702,000
Q2 2022 Aug 12, 2022	BUY	$13.46 - $48.16 $603,896 - $2.16 Million	44,866 New	44,866 $681,000

19.9M

66.8K

60.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $54.2M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.